OrganaBio
Sarah Alter, Ph.D., has 15 years of immunology research experience which includes autoimmunity, cancer, and infectious disease.
Before her position at OrganaBio, Sarah was responsible for leading a team of scientists at Altor Bioscience where she facilitated the advancement of Altor’s technologies. As a Research and Development Manager, Dr. Alter coordinated immunotherapy-focused preclinical and clinical studies and contributed to the progress of Altor’s drug discovery and therapeutic applications.
Sarah received her Doctor of Philosophy from the University of Miami, Miller School of Medicine. She is also a registered Patent Agent, licensed to practice before the United States Patent and Trademark Office. Her work was published in many peer-reviewed journals and presented at national and international business and scientific meetings.
This person is not in any offices
OrganaBio
1 followers
OrganaBio is a CDMO that offers an integrated solution of supply chain, development, and manufacturing resources specifically for cell therapy developers. OrganaBio offers its clients a broad array of expertise across a range of disciplines, including Biomedical Engineering, Cell Biology, Tissue Engineering, Regenerative Medicine, Cell and Gene Therapy, Drug Development, Immunology and Analytical Chemistry.